Advertisement
Screener

INCYTE CORPORATION (INCY) Deferred State and Local Income Tax Expense (Benefit)

2.8 / 5 stars · 66/118 Roast Me

INCYTE CORPORATION Deferred State and Local Income Tax Expense (Benefit)

INCYTE CORPORATION (INCY) reported Deferred State and Local Income Tax Expense (Benefit) of $7.07 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-10

  • INCYTE CORPORATION deferred state and local income tax expense (benefit) for fiscal 2025 was $7.07M, a 67.60% decline from fiscal 2024.
  • INCYTE CORPORATION deferred state and local income tax expense (benefit) for fiscal 2024 was $21.82M.
  • INCYTE CORPORATION deferred state and local income tax expense (benefit) for fiscal 2023 was -$19.63M.
  • INCYTE CORPORATION deferred state and local income tax expense (benefit) for fiscal 2022 was -$3.71M.
Period endDeferred State and Local Income Tax Expense (Benefit) 12 month
2025-12-31$7.07M
10-K · filed 2026-02-10
2024-12-31$21.82M
10-K · filed 2026-02-10
2023-12-31-$19.63M
10-K · filed 2026-02-10
2022-12-31-$3.71M
10-K · filed 2025-02-10
2021-12-31-$57.68M
10-K · filed 2024-02-13
2020-12-31$0.00
10-K · filed 2023-02-07
2019-12-31-$205.00K
10-K · filed 2022-02-08
2018-12-31$111.00K
10-K · filed 2021-02-09
2017-12-31-$805.00K
10-K · filed 2020-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
IQVIA HOLDINGS INC. (IQV)United States$45.926B20.54
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B